Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
115 participants
INTERVENTIONAL
1992-12-31
1994-06-30
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
QUADRUPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Control Infant Formula
Ready-to-Feed (RTF) Soy Infant Formula
Active Comparator: Control Infant Formula
Ready-to-Feed (RTF) Soy Infant Formula
Experimental Infant Formula 1
Experimental Ready-to-Feed Soy Formula
Experimental Infant Formula 1
method A phytate reduction and 5% protein hydrolysis
Experimental Infant Formula 2
Experimental Ready-to-Feed Soy Formula
Experimental Infant Formula 2
method A phytate reduction and 10% protein hydrolysis
Experimental Infant Formula 3
Experimental Ready-to-Feed Soy Formula
Experimental Infant Formula 3
method B phytate reduction and 5% protein hydrolysis
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Experimental Infant Formula 1
method A phytate reduction and 5% protein hydrolysis
Experimental Infant Formula 2
method A phytate reduction and 10% protein hydrolysis
Experimental Infant Formula 3
method B phytate reduction and 5% protein hydrolysis
Active Comparator: Control Infant Formula
Ready-to-Feed (RTF) Soy Infant Formula
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Health infants reported to be tolerating a milk-based formula (Cohorts).
* Infants considered full-term, 2 to 9 weeks of age with a birth-weight above the 5th percentile (NCHS).
2 Weeks
9 Weeks
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Abbott Nutrition
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
John Lasekan, MBA, PhD, CCRP
Role: STUDY_CHAIR
Abbott Nutrition
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Arkansas Children's Hospital
Little Rock, Arkansas, United States
Dreyer Clinic
Aurora, Illinois, United States
T&W Research
Owensboro, Kentucky, United States
Park Nicollet Medical Foundation
Minneapolis, Minnesota, United States
Clinical Studies, Inc
Canton, Ohio, United States
Research Memphis
Memphis, Tennessee, United States
Child Care Associates
San Antonio, Texas, United States
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
AE58
Identifier Type: -
Identifier Source: org_study_id